Brief: Vallon Pharmaceuticals Inc - On Feb 28, Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

GRI Bio

02/03/2023 22:06

March 2 (Reuters) - Vallon Pharmaceuticals Inc  VLON.O :
    * VALLON PHARMACEUTICALS INC - ON FEB 28, GOT NOTICE OF
DELISTING
OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ

Source text: [ID:http://bit.ly/3Z7eQHn]
Further company coverage:  VLON.O 

 ((Reuters.Briefs@thomsonreuters.com;))